What are the AUA-SUO guidelines for use of cystoscopy in the diagnosis of bladder cancer?

Updated: Feb 23, 2021
  • Author: Kara N Babaian, MD, FACS; Chief Editor: Bradley Fields Schwartz, DO, FACS  more...
  • Print
Answer

Joint AUA/SUO guidelines, issued in 2016, recommend that at the time of resection of suspected bladder cancer, a clinician should perform a thorough cystoscopic examination of the patient’s entire urethra and bladder to evaluates and document tumor size, location, configuration, number, and mucosal abnormalities. In a patient with non–muscle-invasive bladder cancer (NMIBC), blue light cystoscopy, if available, should be offered at the time of TURBT to increase detection and decrease recurrence. In a patient with normal cystoscopy and positive cytology and a history of NMIBC, blue light cystoscopy (when available); prostatic urethral biopsies and upper tract imaging, as well as ureteroscopy; or random bladder biopsies should be considerd. [143]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!